Company / PP&E per Share
Arbutus Biopharma Corp PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.07
FY2021-FY2025
Trend
-99.1%
vs FY2024
Sector context
#190 of 191
Health Care
What the data says
Among 191 Health Care companies, Arbutus Biopharma Corp is in the bottom 1% for pp&e per share. PP&E per Share has declined for 8 consecutive years, from $0.22 in FY2017 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -72.5%.
Declined from $0.03 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -83.1%
- 5-Year CAGR
- -72.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's pp&e per share has declined for 8 consecutive years.
- In FY2025, pp&e per share decreased 99.1% year-over-year.
- Ranks #190 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -99.1% |
| FY2024 | $0.02 | -34.4% |
| FY2023 | $0.03 | -15.1% |
| FY2022 | $0.03 | -47.6% |
| FY2021 | $0.07 | -37.6% |
| FY2020 | $0.11 | -31.6% |
| FY2019 | $0.16 | -15.2% |
| FY2018 | $0.18 | -16.7% |
| FY2017 | $0.22 | +74.7% |
| FY2016 | $0.13 | +117.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026